Tag: treatment option

May 9, 2018

Kura Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update

Kura Oncology (Nasdaq:KURA) a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today reported first quarter...
May 7, 2018

Aclaris Therapeutics Announces Availability of ESKATA (Hydrogen Peroxide) Topical Solution, 40% (w/w)

Aclaris Therapeutics (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company, today announced that ESKATA™ is now available for purchase by dermatologists in the...
April 26, 2018

FDA Determines that Afrezza REMS Communication Plan Has Met Goals and REMS No Longer Necessary

MannKind (Nasdaq:MNKD), focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and...
April 24, 2018

Alder BioPharmaceuticals Presents New 12-Month Data of Eptinezumab in PROMISE 1 Phase 3 Trial Showing Long-Term Reduction in Episodic Migraine

Alder BioPharmaceuticals (NASDAQ:ALDR) a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today announced new...
April 23, 2018

Medtronic IN.PACT Admiral Drug Coated Balloon Receives FDA Approval to Treat Long SFA Lesions

Medtronic (NYSE:MDT) today announced that it has received U.S. Food and Drug Administration (FDA) approval for the IN.PACT(TM) Admiral(TM) Drug-Coated...
April 17, 2018

Shire Receives FDA Approval for Rare Disease Drug, Share Price Rises

Shire has received another FDA approval with the second approval for Vonvendi, a treatment for perioperative bleeding management in adults...
April 17, 2018

Medtronic Expands Focus on Interventional Oncology with Its U.S. Launch of OptiSphere Embolization Spheres

Medtronic (NYSE: MDT) announced its U.S. launch of OptiSphere embolization spheres, a resorbable embolic platform designed for embolization of hypervascular...